文献速递慢阻肺

COPD共病特征与两年急性及出院后照护使用轨迹

COPD Comorbidity Profiles and 2-Year Trajectory of Acute and Postacute Care Use.
PubMed 文献 · Chest · 2021-01-19

本研究在91,453例COPD患者中采用潜在类别分析识别出四种共病特征,随Charlson共病指数升高,两年内全因急性照护(住院、观察、急诊)及出院后照护使用风险呈显著递增。

要点

  • 基于电子健康档案诊断码可识别COPD患者四种共病特征。
  • 共病特征与后续急性及出院后照护使用风险增加相关。
  • COPD管理风险分层应考虑整合共病特征。

核心结论

  • COPD患者可基于标准电子健康档案诊断码识别出四种共病特征,且与后续急性及出院后照护使用相关。

研究设计与样本

  • 回顾性队列研究,纳入2011至2015年91,453例COPD患者,采用潜在类别分析识别共病特征。
  • 使用Charlson共病指数中的特定共病,并校正三个研究点不同共病基础患病率的差异。
  • 通过多变量逻辑回归比较不同类别的急性及出院后照护使用率。

主要发现

  • 平均年龄71±11岁,55%为女性,23%为有色人种,80%为既往或当前吸烟者。
  • 潜在类别分析识别四种共病特征:低共病(61%;Charlson指数1.9±1.4)、代谢肾脏(21%;4.7±1.8)、心血管(12%;4.6±1.9)和多重共病(7%;7.5±1.7)。
  • 两年随访中,随共病特征Charlson指数升高,全因急性照护(住院、观察、急诊)及出院后照护使用的比值呈显著且不重叠的增加。

临床怎么用

  • 可利用电子健康档案诊断码识别COPD共病特征,用于人群风险分层。
  • 针对共病特征实施端到端综合COPD管理,可能减少急性及出院后照护使用。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Multiple morbidity is the norm in advanced COPD and contributes to high symptom burden and worse outcomes. RESEARCH QUESTION: Can distinct comorbidity profiles be identified and validated in a community-based sample of patients with COPD from a large integrated health care system using a standard, commonly used diagnostic code-based comorbidity index and downstream 2-year health care use data? STUDY DESIGN AND METHODS: In this retrospective cohort study, we used latent class analysis (LCA) to identify comorbidity profiles in a population-based sample of 91,453 patients with a COPD diagnosis between 2011 and 2015. We included specific comorbid conditions from the Charlson Comorbidity Index (CCI) and accounted for variation in underlying prevalence of different comorbidities across the three study sites. Sociodemographic, clinical, and health-care use data were obtained from electronic health records (EHRs). Multivariate logistic regression analysis was used to compare rates of acute and postacute care use by class. RESULTS: The mean age was 71 ± 11 years, 55% of patients were women, 23% of patients were people of color, and 80% of patients were former or current smokers. LCA identified four distinct comorbidity profiles with progressively higher CCI scores: low morbidity (61%; 1.9 ± 1.4), metabolic renal (21%; 4.7 ± 1.8), cardiovascular (12%; 4.6 ± 1.9), and multimorbidity (7%; 7.5 ± 1.7). In multivariate models, during 2 years of follow-up, a significant, nonoverlapping increase was found in the odds of having any all-cause acute (hospitalizations, observation stays, and ED visits) and postacute care use across the comorbidity profiles. INTERPRETATION: Distinct comorbidity profiles can be identified in patients with COPD using standard EHR-based diagnostic codes, and these profiles are associated with subsequent acute and postacute care use. Population-based risk stratification schemes for end-to-end, comprehensive COPD management should consider integrating comorbidity profiles such as those found in this study.

来源:Chest,查看原文。版权归原作者所有。

引用

  1. Shen E, Lee JS, Mularski RA, et al. COPD Comorbidity Profiles and 2-Year Trajectory of Acute and Postacute Care Use. Chest. 2021. PMID: 33482176. doi:10.1016/j.chest.2021.01.020

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。